Prominent IP Updates on Dec 19, 2014
EU's top court opens door to some stem cell patents (Reuters) - Europe's top court has opened the door to certain stem cell patents in the European Union by ruling…
“Intellectual Property Rights: Understanding and Protecting Your Creations
Prominent IP Updates on Dec 18, 2014
Heartburn Relief: AstraZeneca Wins Nexium Antitrust Trial An 11-person jury decided in favor of defendants AstraZeneca PLC and Ranbaxy Laboratories, Inc. in the first pay-for-delay class action trial since the…
Prominent IP Updates on Dec 16, 2014
EFF to Challenge Podcasting Patent Before USPTO The Electronic Frontier Foundation (EFF) will argue at a public hearing Wednesday that the U.S. Patent and Trademark Office (USPTO) should invalidate key…
Prominent IP Updates on Dec 17, 2014
Google and Verizon Enter Into Global Patent License Agreement Verizon Communications Inc. and Google Inc. have entered into a long-term patent cross-license agreement covering a broad range of products and…
Patent Portfolio and Patent Strength Mapping: Quality Matters Over Quantity?
The value of Intellectual property (Read: Patents) is increasing in today’s technological world. The market, value, growth of any company depends on the technological prowess it has or in other…
Can You Afford the R&D Cost Cut during Recession?
Research expenses are mandatory for all technology firms and they have to support research, even during these recession times, as any breakthrough can aid them in surmounting this recession demon.…
AIA Filings on 15 December 2014
Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. filed Three Inter Partes Review (IPR) petetions on Monday December 15, 2014. Out of three, two IPRs were filed against BIOGEN…
- Go to the previous page
- 1
- …
- 21
- 22
- 23
- 24